The Supreme Court rejected an effort to restrict the abortion pill mifepristone from the marketplace, ruling unanimously that the plaintiffs lacked standing. A number of anti-abortion medical associations and several doctors challenged the Food and Drug Administration’s relaxed restrictions on access to the drug. But the justices ruled that the plaintiffs lacked sufficient standing, as […]
